Research

Natural peptide PEPITEM shows promise in reducing arthritic joint swelling

by

PEPITEM: A Potential Game-Changer in Arthritis Treatment? New research suggests a naturally occurring immunopeptide, PEPITEM, could offer a significant advancement in the treatment of inflammatory arthritis, potentially rivaling current standard-of-care options. Scientists at the University of Birmingham, who initially discovered PEPITEM and characterized the Adiponectin-PEPITEM pathway, have demonstrated promising results in both human and animal … Read more

Study reveals brain mechanisms behind post-stroke urinary incontinence

by

Unlocking Bladder Control: How Brain Research is Transforming Stroke Recovery For millions of stroke survivors, regaining independence extends beyond physical mobility. A significant, often overlooked challenge is urinary incontinence, affecting up to 79% of patients immediately following a stroke and persisting in nearly 40% a year later. Now, groundbreaking research from USC’s Keck School of … Read more

EV-RNAs show promise for IBD diagnosis and treatment

by

The Future of IBD Treatment: Harnessing the Power of EV-RNAs Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease and ulcerative colitis, affects millions worldwide and is projected to impact over 1% of the population in early-industrialized countries by 2045. A recent comprehensive review published in ExRNA, led by researchers at Sir Run-Run Shaw Hospital, Zhejiang University … Read more

Landmark study establishes shared definition of mental wellbeing

by

Defining Wellbeing: A Novel Era for Mental Health For decades, the concept of ‘mental wellbeing’ has been remarkably elusive, a widely used term with little consensus on its true meaning. Now, groundbreaking research led by Adelaide University and Be Well Co is poised to change that, offering a unified understanding of what it actually means … Read more

AI analyzes Reddit posts to find underreported GLP-1 side effects

by

The Rise of ‘Computational Social Listening’: How AI is Uncovering Hidden Drug Side Effects For decades, identifying drug side effects relied heavily on clinical trials and post-market reporting. Now, a new approach is gaining traction: analyzing the vast ocean of patient experiences shared on social media. Researchers at the University of Pennsylvania have pioneered a … Read more

New embodied AI system teaches users complex movements via muscles

by

The Rise of ‘Embodied AI’: When Artificial Intelligence Feels Like a Gentle Hand Imagine learning a novel skill – opening a tricky jar, using a foreign appliance, or even performing a delicate physical therapy exercise – and feeling a subtle, guiding force on your own muscles. This isn’t science fiction; it’s the emerging reality of … Read more

Sylvester Comprehensive Cancer Center opens new trial for neuroendocrine tumors

by

Hope on the Horizon: New Trial Targets Aggressive Neuroendocrine Tumors A new clinical trial at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is offering a beacon of hope for patients battling high-grade neuroendocrine tumors (NETs). These complex and aggressive cancers have historically seen limited medical advancements due to … Read more

Study identifies four radiomic profiles linked to sarcoidosis severity

by

Revolutionizing Sarcoidosis Diagnosis: How AI-Powered CT Scans Are Changing the Game For the over 150,000 Americans living with sarcoidosis, a complex inflammatory lung disease, diagnosis and monitoring have long been a challenge. Traditional methods rely on visual assessment of chest CT scans, a process prone to variability between specialists. But a recent era in sarcoidosis … Read more

CAR T therapy induces remission in multiple autoimmune diseases

by

CAR-T Therapy: A Fresh Hope for Autoimmune Disease? A groundbreaking case study published in Med details the successful use of CAR-T cell therapy to treat a patient battling not one, but three, autoimmune diseases simultaneously. This marks a significant step forward in exploring the potential of this “living drug” beyond cancer treatment, offering a potential … Read more

Fat-producing enzyme identified as key driver of damage in Parkinson’s disease

by

Parkinson’s Disease: A New Target in Fat Metabolism? A newly identified enzyme, glycerol-3-phosphate acyltransferase (GPAT), is emerging as a potential key player in the progression of Parkinson’s disease. Research from Nanyang Technological University, Singapore (NTU Singapore) suggests that GPAT’s role in fat production within brain cells could amplify the damage caused by the protein α-synuclein, … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]